Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Intrexon's field trial of genetically altered mosquitoes in Florida Keys hits bump in road, most voters oppose the study

Published 11/09/2016, 09:53 AM
Updated 11/09/2016, 09:53 AM
Intrexon's field trial of genetically altered mosquitoes in Florida Keys hits bump in road, most voters oppose the study
  • Intrexon (XON +5.2%) is riding the initial bullish biotech wave after the Trump victory, but there is a bit of bad news related to a U.S. field trial of subsidiary Oxitec's genetically altered mosquitoes, OX513A, to assess their ability to reduce the spread of diseases like Zika, dengue, yellow fever and chikungunya.
  • The proposed study will be conducted in Florida's Key Haven, an island in the lower keys with ~1,000 residents, most of which apparently take a dim view of the project. In a ballot vote yesterday, almost 2/3 oppose it. In a countywide referendum, however, ~58% support it.
  • Key Haven residents don't want their area used as an experiment site because they perceive a lack of evidence that the engineered Aedes aegypti mosquitoes are safe for the environment.
  • The results of the referendums are nonbinding. The ultimate decision will be made by the five-member Florida Keys Mosquito Control District. Most residents expect it to follow the majority vote but the split makes the decision more uncertain.
  • Previously: Oxitec's proposed U.S. trial of genetically altered mosquitoes clears initial hurdle (March 14)

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.